API Manufacturer from India - Looking for Strategic Investor

Company was estabilished in the year 2004 by a group of technocrats from renowned Dr.Reddys Laboratories Limited. All the key personnel have expertise in their respective areas of specialization. Strong R&D, Analytical capabilities, versatile human resources and well vision management are the core competencies of the company.
Today the Group is operating with one Intermediate manufacturing unit and one API manufacturing unit both are located in Pashamylaram IDA, 25 KMs away from Hyderabad.

Annual Turnover : USD. 6.5 Millions

Number of Employees : 100

Property : 2 well built cGMP compliant manufacturing facilities and one upcoming API manufacturing Site around Hyderabad, India. Office and commercial analytical lab is in rented premises.

Production Lines : Active Pharmaceutical Ingredients and Pharma Intermediates.

Products manufactured : Producer of 8 generic APIs and several Pharma Intermediates. Company is in the process of registering these APIs in several Europe,Latin America, Middle east and East -asian countries. Drug Master file is avaialbe for one of the major product.

Products in development : Company has 5 more generic APIs at different stages of development.

Drug Master files : . Drug Master file is available for one of the major product.
DMFs are under preparation for 3 more products. DMF s are targeted for European and US markets.

Short Company Profile :

Company was estabilished in the year 2004 by a group of technocrats from renowned Dr.Reddys Laboratories Limited. All the key personnel have expertise in their respective areas of specialization. Strong R&D, Analytical capabilities, versatile human resources and well vision management are the core competencies of the company.
Today the Group is operating with one Intermediate manufacturing unit and one API manufacturing unit both are located in Pashamylaram IDA, 25 KMs away from Hyderabad.

Despite having strong innovative and technical approaches, company has been struggling with its financial resources to construct a new manufacturing Unit near by ZAHIRABAD. This is one of the core area where company is lacking behind. Hence looking for Strategic Investors. Investors from Pharmaceutical / Generic Pharma background are preferred.

We invite all the potential investors from across the globe from this ground.

• Long-term pricing & reimbursement strategies to penetrate significant growth markets (09/07/2010)
• Prostate Cancer (07/05/2010)
• Investement in Life Science Companies (25/02/2010)

• Turkey - Company for Sale (19/05/2009)

---